3Berden A, Goceroglu A,Jayne D,et al. Diagnosis and management of ANCA associated vasculitis[ J]. BMJ,2012,344 :e26.
4Suka M, Hayashi T, Kobayashi S, et al. Improvement in health-related quality of life in MPO-ANCA-associated vasculitis patients treated with cyclophosphamide plus prednisolone : an analysis of 18 months of follow-up data from the JMAAV study [ J ]. Mod Rheumatol, 2012, [Epub ahead of print ].
1Jayne D, Rasmussen N,Andrassy K et al. A randomized trial of ma- intenance therapy for vasculitis associated with antineutrophil cyto- plasmic autoantibodies[ J]. N Engl J Med,2003,349:3644.
2Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomato- sis[J]. N Engl J Med,2005,352:351-361.
3De Groot K, Rasmussen N, Bacon PA et al. Randomized trial of cy- clophosphamide versus methotrexate for induction of remission in ear- ly systemic antineutrophil cytoplasmic antibody-associated vasculitis [ J]. Arthritis Rheum,2005,52:2461-2469.
4John H, Stone M D, Peter A. Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis [ J ]. N Engl J Med, 2010,363 : 221- 232.
5Stone JH, Holbrook JT, Marriott MA et al. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial. Arthritis Rheum [ J ]. 2006,54 : 1608-1618.
6de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, et al. Clini- cal and histologic determinants of renal outcome in ANCA-associated vasculitis :A prospective analysis of 100 patients with severe renal in- volvement[ J]. J Am Soc Nephrol,2006,17:2264 -2274.
7Appel GB, Kaplan AA,Stone JH. Initial and maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis [ J ]. Up To Date Online,version 14.3.
